Snapshot from Sep 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech Medical conference

Sky Labs CART BP Monitor ESC 2026

Analysis based on 9 articles · First reported Jul 20, 2026 · Last updated Sep 07, 2026

Sentiment
30
Attention
2
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The positive clinical validation at a major cardiology congress could enhance Sky Labs' reputation and accelerate adoption of its CART monitor, potentially increasing sales and market share in the wearable blood pressure monitoring segment. This may also boost investor confidence in the company's technology and growth prospects.

Medical devices Healthcare Wearable technology

Sky Labs presented clinical research on its ring-type blood pressure monitor, CART, at ESC Congress 2026 in Munich, Germany. The company hosted five dedicated sessions presenting new clinical data on atrial fibrillation (AF) and heart failure (HF) patients for the first time. Studies demonstrated high analyzable data rates and agreement with conventional ABPM, meeting ESH error margin criteria. The device uses PPG sensors and AI deep learning for 24-hour cuffless BP measurement. It is prescribed in over 2,000 Korean medical institutions with over 300,000 cumulative prescriptions and was recommended in the 2026 Korean Society of Hypertension Guidelines, a world-first for ring-type cuffless monitors. Sky Labs aims to expand into European and global markets.

per
As CEO, he announced the results and expansion plans, representing leadership and strategic direction.
Importance 60.0 Sentiment 70.0
ngo
Hosted the ESC Congress 2026 where the data was presented, providing a prestigious platform.
Importance 50.0 Sentiment 0.0
ngo
Its validation criteria were met, lending credibility to the device.
Importance 40.0 Sentiment 0.0
cnt
Home country of Sky Labs and primary market; regulatory and clinical success here supports global expansion.
Importance 30.0 Sentiment 0.0
ngo
Recommended CART in its 2026 guidelines, a significant endorsement.
Importance 30.0 Sentiment 0.0
priv
Conducted AF study with CART, contributing clinical evidence.
Importance 30.0 Sentiment 0.0
priv
Conducted HF study with CART, contributing clinical evidence.
Importance 30.0 Sentiment 0.0
per
Presented AF study results, supporting CART's utility.
Importance 30.0 Sentiment 0.0
per
Presented HF study results, supporting CART's reliability.
Importance 30.0 Sentiment 0.0
govactor
Recognized CART BP pro for reimbursement, facilitating adoption in Korea.
Importance 20.0 Sentiment 0.0
cnt
Host country of the ESC Congress, providing an international venue.
Importance 20.0 Sentiment 0.0
priv
Validated CART against ESH recommendations.
Importance 20.0 Sentiment 0.0
priv
Presented case study on medication reduction using CART.
Importance 20.0 Sentiment 0.0
priv
Analyzed sleep apnea data with CART.
Importance 20.0 Sentiment 0.0
per
Reaffirmed CART's reliability through ESH tests.
Importance 20.0 Sentiment 0.0
+ 4 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.